Trulieve Cannabis (TRUL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
12 Jun, 2026Executive summary
A special meeting is scheduled for August 5, 2026, to vote on a plan of arrangement to domesticate the company from British Columbia to Delaware, USA, under Section 288 of the BCBCA.
The Delaware Domestication aims to align the corporate structure with U.S. operations, enhance access to U.S. capital markets, and streamline regulatory compliance.
Shareholders will not experience dilution; all shares, options, and awards will convert on a one-for-one basis to Delaware equivalents.
The board unanimously recommends voting in favor of the arrangement and adjournment proposals.
Voting matters and shareholder proposals
Shareholders will vote on: (1) approving the Delaware Domestication plan of arrangement, and (2) authorizing adjournment of the meeting if more votes are needed.
Approval requires a two-thirds majority of both Subordinate and Multiple Voting Shares, voting together and separately.
Shareholders may submit proposals or director nominations for future meetings, subject to SEC and BCBCA rules and deadlines.
Board of directors and corporate governance
The board will initially consist of seven directors post-domestication, with no expected changes to current directors or officers.
Delaware law will govern director qualifications, removal, and board vacancies, with detailed provisions in the new bylaws.
Advance notice provisions for director nominations and shareholder proposals are included in the bylaws.
Latest events from Trulieve Cannabis
- Market leader in U.S. medical cannabis, poised for growth with NYSE listing and tax relief.TRUL
Investor presentation7 Jun 2026 - 2024 revenue up 5% to $1.2B, with record cash flow and ongoing IRS 280E tax challenge.TRUL
Q4 202422 May 2026 - Q2 2025 delivered $302M revenue, 61% margin, $111M EBITDA, and strong cash flow.TRUL
Q2 202522 May 2026 - Q1 revenue hit $287M with 59% margin, $100M EBITDA, and regulatory changes fueling growth.TRUL
Q1 20267 May 2026 - 2025 revenue hit $1.2B with 60% gross margin, record EBITDA, and strong cash flow.TRUL
Q4 202526 Feb 2026 - Q2 revenue hit $303M, margins expanded, and tax uncertainties remain a key risk.TRUL
Q2 20242 Feb 2026 - Strong Q2 retail growth, robust loyalty adoption, and Florida poised for rapid adult-use expansion.TRUL
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase2 Feb 2026 - Q3 revenue up 3% to $284M, 61% gross margin, $96M adjusted EBITDA, net loss $60M.TRUL
Q3 202416 Jan 2026 - Retail expansion, operational efficiency, and customer focus drive growth amid evolving regulations.TRUL
27th Annual Needham Growth Conference10 Jan 2026